Click "Continue" to leave Medscape Education and access MedscapefromWebMD
ContinueCancel
 
 
 

Noncolorectal Gastrointestinal Cancer
CME Learning Center

 
 

CME Activities

  • Management of Advanced Gastric Cancer CME Platinum and fluoropyrimidine chemotherapy are still standard treatment for the management of advanced gastric cancer, and use of additional anthracycline or taxane is controversial.
    Expert Review of Gastroenterology and Hepatology, April 2012
  • A Silent Epidemic: Why Chronic Hepatitis B Matters   CME Whom to screen? Whom to vaccinate? Drs Perrillo and Ward discuss the challenges posed by the hepatitis B silent epidemic.
    Medscape Education Family Medicine, March 2012
  • New Strategies for Treatment: Pancreatic Adenocarcinoma   CME Where are we with pancreatic adenocarcinoma? Do novel agents targeting mechanisms of tumor promotion provide hope for survival?
    Medscape Education Oncology, February 2012
  • Pancreatic Cancer: An Endoscopic Perspective CME The current review highlights the state of the art in the use of endoscopic ultrasound for the diagnosis and treatment of pancreatic cancer.
    Expert Review of Gastroenterology and Hepatology, January 2012
  • Hepatocellular Carcinoma Preventable With Modifiable Risk Factors CME According to researchers, strong links exist between liver cancer and the modifiable risk factors of smoking, heavy alcohol consumption, obesity, and chronic infection with hepatitis B or C.
    Medscape Education Clinical Briefs, November 2011
    • More
 

Latest Clinical Briefs in Noncolorectal Gastrointestinal Cancer

 
 

About Noncolorectal Gastrointestinal Cancer

    Noncolorectal gastrointestinal cancers include pancreatic, hepatobiliary, gastric, small bowel, and esophageal cancer. Pancreatic cancer has the worst prognosis of these cancers with a 5-year survival rate of less than 5%. Treatment of noncolorectal gastrointestinal cancers often includes a multimodal approach combining surgery, radiotherapy, and chemotherapy. Targeted therapies and biologic therapies are currently being investigated in many of these tumor types, and healthcare practitioners are challenged to remain up to date on the emerging clinical data for noncolorectal gastrointestinal cancers.
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by Medscape, LLC. This website also contains material copyrighted by 3rd parties.